Expansion of structure biology studies on human defense and response proteins for drug design based on three-dimensional-structures
扩展人类防御和反应蛋白的结构生物学研究,用于基于三维结构的药物设计
基本信息
- 批准号:14370727
- 负责人:
- 金额:$ 8.77万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
For drug design based on three-dimensional structures of defense and response proteins such as human receptors and disease-related enzymes, structural biology studies utilizing X-ray crystallography are carried out on these proteins. The studies have further expanded the methods for structure study and their application.Bacterial Lipopolysaccharide is recognized by human MD-2 proteins that associated with human Toll-Like receptor 4 (TLR4). The TLR4 complex with MD-2 transmits bacterial infection signals to cell cytosol, triggers defense response to the infection, and causes endotoxin shocks known as septicemia. Human and mouse MD-2 proteins are expressed in yeast and then highly purified. Crystals are obtained for human MD-2. Attempts to express human TLR4 are also carried out. Human heat-shock protein HSP40 and β2 trans-membrane receptor are also expressed, purified, and subjected to crystallization attempts.Human β-galactosidasese and α-N-acetylgalactosaminidase are lysosomal enzymes … More hydrolyzes galactoside linkages in various glycolipids, and its genetic mutations decrease enzymatic activities which result in deficiencies of glycolipid metabolism and hence accumulate substrates in organs, causing lysosomal diseases. These enzymes are expressed and subjected to crystallographic studies. The structure of human tissue factor protein in complex with humanized antibody Fab is determined for drug design of blood-coagulation inhibitorsYeast homing endonuclease derived from VMA1 gene is structurally studied for full elucidation of its binding to double-stranded substrate DNAs. To elucidate its precise reaction mechanisms of protein splicing in this endonuclease, a series of crystal structural studies has been carried out with the use of splicing-inactive and slowly spliceable precursors. Pathogenic protein SEp22 from Salmonella enteritidis is expressed, purified, and crystallized. The structure of SEp22 determined for two crystal forms has revealed 12-subunitit oligomer in 23 symmetry and iron ion binding for protection of its DNA. Cassette recombinases of Staphylococcus aureus (SA) are expressed and purified for understanding of methicillin-resistant SA diseases. Less
对于基于防御和反应蛋白的三维结构(例如人体受体和疾病相关酶的生物学研究)的药物设计,使用X射线晶体图的生物学研究是在蛋白质上进行的。 2与人Toll样受体4相关的蛋白质(TLR4)与MD-2的复合物传递给细胞溶胶,触发对感染的防御反应,并引起内毒素冲击。 Shock Protein HSP40 and β2 Trans -Membrane Receptor Are Also Expressed, and Subjected to Crystallization Attempts.human β-GalactoseSASESESESESESAM Inidase Are Lysosomal Enzymes ... More Hydroryzzide Linkages in Various Glycolipids Ties Which Result in Deficiencies of Glycolipid Metabolism and Henstrate SubstrateS in Organs,这些酶进行了晶体学研究。为了在此内核酸酶中阐明其剪接的原理,一系列的晶体研究是用什一堂什一堂的tith tith tithe tithe tith tith the the the the the tith tith the the the the the the the the the the the the the the the the the the the the the the the the the在23个对称性中揭示了12个亚基的寡聚,并且对其DNA的保护(SA)进行了纯化和净化。
项目成果
期刊论文数量(97)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Crystal Structure of Spliceable Precursors of Yeast VMA1-Derived Homing Endonuclease
酵母 VMA1 衍生的归巢核酸内切酶的剪接前体的晶体结构
- DOI:
- 发表时间:2002
- 期刊:
- 影响因子:0
- 作者:R.Mizutani;S.Nogami;M.Kawasaki;Y.Ohya;Y.Anraku;Y.Satow
- 通讯作者:Y.Satow
Crystal Structure of the Human Tissue Factor Complex with Its Cognate Humanized Antibody Fab : Structural Basis of the Inhibition of Blood Coagulation
人体组织因子复合物及其同源人源化抗体 Fab 的晶体结构:抑制凝血的结构基础
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:U.Ohto;R.Mizutani;M.Nakamura;H.Adachi;Y.Satow
- 通讯作者:Y.Satow
U.Ohto, R.Mizutani, M.Nakamura, H.Adachi, Y.Satow: "Crystal Structure of the Human Tissue Factor Complex with Its Cognate Humanized Antibody Fab : Structural Basis of the Inhibition of Blood Coagulation"J.Pharm.Soc.Jpn.. 123・S2. 203 (2003)
U.Ohto、R.Mizutani、M.Nakamura、H.Adachi、Y.Satow:“人体组织因子复合物及其同源人源化抗体 Fab 的晶体结构:抑制血液凝固的结构基础”J.Pharm.Soc .日本..123・S2.203 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
水谷 隆太, 佐藤 能雅, 安楽 泰宏: "タンパク質スプライシング反応の化学機構"蛋白質核酸酵素. 49. 18-27 (2003)
Ryuta Mizutani、Yoshimas Sato、Yasuhiro Anraku:“蛋白质剪接反应的化学机制”《蛋白质核酸酶》49. 18-27 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Structure-based design of a low-molecular weight inhibitor of human tissue factor initiating blood coagulation
基于结构的低分子量人体组织因子凝血抑制剂的设计
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:F.Kondoh;U.Ohto;R.Mizutani;Y.Satow.
- 通讯作者:Y.Satow.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATOW Yoshinori其他文献
SATOW Yoshinori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATOW Yoshinori', 18)}}的其他基金
Studies on three-dimensional structures of the glycolytic enzymes responsible for the lysosomal diseases
负责溶酶体疾病的糖酵解酶的三维结构研究
- 批准号:
12470486 - 财政年份:2000
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Rapid and Accurate Methods for X-ray Crystallography to Study Crystal Structures and Functions of Proteins.
开发快速准确的 X 射线晶体学方法来研究蛋白质的晶体结构和功能。
- 批准号:
06305006 - 财政年份:1994
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Co-operative Research (A)
Establishment of X-Ray Structure Analysis System for Protein Crystals by Multiwavelength Anomalous Diffraction Methods.
多波长反常衍射方法建立蛋白质晶体X射线结构分析系统。
- 批准号:
02402051 - 财政年份:1990
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Development of Crystal Structure Analysis Methods for Small Protein Crystals Using Anomalous Scattering.
利用反常散射开发小蛋白质晶体的晶体结构分析方法。
- 批准号:
02558011 - 财政年份:1990
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似国自然基金
基于Brigatinib复合物结构指导的抗肺癌EGFR T790M/C797S新药设计与研发
- 批准号:81903539
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
蓝光受体蛋白隐花素激活与调控的分子机理研究
- 批准号:31870727
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
染色质重塑因子Fun30/Fft3与核小体复合物的结构生物学研究
- 批准号:31800632
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
MYST家族乙酰转移酶HBO1活性调控的分子机制研究
- 批准号:31800622
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IFP35和NMI的复合体结构及其分泌调控机制
- 批准号:31870739
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
- 批准号:
478278 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Operating Grants
Structure and Function of Cullin3 E3 ligase complexes
Cullin3 E3 连接酶复合物的结构和功能
- 批准号:
489003 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Operating Grants
Fixed-Target Platforms for Time-Resolved Crystallography
用于时间分辨晶体学的固定目标平台
- 批准号:
10634328 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Biophysical, Structural, and Cellular Dissection of COPI-Dependent Retrograde Trafficking Using a Coronavirus Toolkit
使用冠状病毒工具包对 COPI 依赖性逆行贩运进行生物物理、结构和细胞解剖
- 批准号:
10646999 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别: